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a 20 kb DNA fragment and is characterized by the
presence of five DNaseI hypersensitive sites in erythroid
cells, termed 5 ¢ HS1-5. A fully active 6.5 kb version of the
LCR, called the m LCR, has been described. Expression of
the b -like globin genes is absolutely dependent on the
presence of the LCR. The developmental expression
pattern of the genes in the cluster is achieved through
competition of the promoters for the activating function
of the LCR. Transgenic mice experiments suggest that
subtle changes in the transcription factor environment
lead to the successive silencing of the embryonic e -globin
and fetal g -globin promoters, resulting in the almost
exclusive transcription of the b -globin gene in adult ery-
thropoiesis. In this paper, we have asked the question
whether the LCR and its individual hypersensitive sites
5 ¢ HS1-4 can activate a basic promoter in the absence of
any other globin sequences. We have employed a minimal
promoter derived from the mouse Hsp68 gene driving the
bacterial b -galactosidase (lacZ) gene. The results show
that the m LCR and 5 ¢ HS3 direct erythroid-specific,
embryonic expression of this construct, while 5 ¢ HS1,
5 ¢ HS2 and 5 ¢ HS4 are inactive at any stage of development.
Expression of the m LCR and 5 ¢ HS3 transgenes is
repressed during fetal stages of development. The trans-
genes are in an inactive chromatin conformation and the
lacZ gene is not transcribed, as shown by in situ hybrid-
ization. These data are compatible with the hypothesis
that the LCR requires the presence of an active promoter
to adopt an open chromatin conformation and with
models proposing progressive heterochromatization
during embryogenesis. The results suggest that the
presence of a b -globin gene is required for LCR function
as conditions become more stringent during development.
Key words: locus control region, b -globin, lacZ gene, basic
promoter, erythropoiesis, embryonic expression pattern, DNaseI
hypersensitive sites, transgenic mice, mouse
SUMMARYINTRODUCTION
The locus control region (LCR) of the human b -globin multi-
gene cluster is a cis-acting regulatory element present 5-25
kb upstream of the e -globin gene. The cluster contains five
developmentally regulated genes in the order 5 ¢ -embryonic
( e ), fetal ( g G and g A) and adult ( d and b )-3 ¢ . The regulatory
function of the LCR became first apparent from the study of
a Dutch thalassemia (Kioussis et al., 1983) and other
naturally occurring deletions of the region where the intact
globin gene is not activated (Driscoll et al., 1989; Taramelli
et al., 1986). It has been shown that deletion of the LCR not
only affects expression of the genes, but also the chromatin
structure of the locus over a distance of at least 200 kb
(Forrester et al., 1990).
Chromatin analysis of the LCR showed that it contains a set
of developmentally stable DNaseI-hypersensitive sites (HS)
termed 5¢ HS1-5 (Grosveld et al., 1987; Tuan et al., 1985).
Various studies have been undertaken to understand the natureand function of this region. These studies revealed that the
LCR, when coupled to globin genes in cis, confers high level,
copy-number dependent- and position-independent expression
to these genes in erythroid tissues in transgenic mice (Grosveld
et al., 1987; Ryan et al., 1989; Talbot et al., 1989). 5¢ HS2-4
also have these properties when linked as single HS to the b -
globin gene (Fraser et al., 1990). Transfection studies stated
that only 5¢ HS2 acts as an enhancer in transient assays (Tuan
et al., 1989; Moon and Ley, 1991). 
A fully active 6.5 kb version of the LCR containing 5¢ HS1-
4, termed the m LCR, has been described (Talbot et al., 1989).
Further dissection of the m LCR revealed that the activity of
each HS can be localized to 200-300 bp core fragments coin-
ciding with the position of hypersensitivity in chromatin
(Philipsen et al., 1990; Pruzina et al., 1991; Talbot et al., 1990).
The minimal element required for LCR activity of 5¢ HS3 was
assigned to a 125 bp fragment (Philipsen et al., 1993). Inter-
estingly, recent observations from our laboratory suggest that
5¢ HS3 is the only site that possesses significant chromatin
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1996). 
The LCR core fragments all contain binding sites for the
erythroid-specific protein GATA-1, and ‘GGTGG’ or ‘CACC’
box motifs binding members of the Sp1 family of transcription
factors (Ellis et al., 1993; Philipsen et al., 1990, 1993; Pruzina
et al., 1991, 1994; Talbot et al., 1990). This combination of
binding sites is also found in the promoters and enhancers of
the b -globin locus as well as many other erythroid-specific
genes (Philipsen et al., 1990 and references therein). Hence,
we have asked whether the m LCR and its individual HS can
function in the absence of any other erythroid regulatory
elements. To answer this, we have used the bacterial lacZ gene
driven by a non-erythroid, 80 bp minimal promoter derived
from the mouse heat shock protein 68 (Hsp68) gene (Kothary
et al., 1987, 1988, 1989). The results show that only the m LCR
and 5¢ HS3 are able to direct the expression of this gene in the
erythroid lineage reproducibly. Interestingly, expression is
limited to the embryonic stages of development, after which
the chromatin of the transgenes is in an inactive conformation
and transcription is repressed. Our data suggest that the
presence of a b -globin gene is essential for LCR function in
definitive erythroid cells, implying that there are more stringent
requirements for erythroid-specific gene expression in later
developmental stages than during the embryonic period.
MATERIALS AND METHODS
Transgenic mice and embryo collection
Five different fragments, 5 ¢ HS4 (2.1 kb BamHI-XbaI), 5 ¢ HS3 (1.9 kb
HindIII), 5 ¢ HS2 (1.5 kb Asp718-BglII), 5 ¢ HS1(1 kb SstI (partial)-
Hind III) and m LCR (6.5 kb, containing 5 ¢ HS1-4) (Talbot et al., 1989)
were linked to the mouse Hsp68 minimal promoter driving the
bacterial lacZ reporter gene. Each of these fragments was isolated as
described (Kollias et al., 1986). The fragments were dissolved in
micro-injection buffer (10 mM Tris-Cl, pH 7.5 and 0.1 mM EDTA)
at a concentration of 1-2 m g/ml and microinjected into the pronucleus
of FVB fertilized mouse eggs. The injected eggs were transferred into
the oviducts of pseudo-pregnant foster females as described (Kollias
et al., 1986).
For the ‘transient’ assay, the foster females were killed 13.5 days
after egg transfer and the fetuses were collected from the uterus. For
stable lines, transgenic founders were bred to non-transgenic mice.
After the lines were established the F1 or F2 males were used for
mating with non-transgenic females for the collection of embryos and
fetuses at various stages of development.
DNA analysis
Genomic mouse DNA was prepared from part of the body of the
fetuses or tail clips from adult mice. The DNA was cut with EcoRI,
Southern blotted and probed with lacZ to detect the transgene. A
fragment from the mouse ThyI gene was used as a loading control
(Talbot et al., 1990).
DNaseI hypersensitive site mapping
Nuclei were isolated from 8-10 transgenic fetal livers (embryonic day
13.5, E13.5) and DNaseI hypersensitive site mapping was performed
as described (Ellis et al., 1996). After this treatment the DNA was
isolated and analyzed by digesting with EcoRI. The blots were first
hybridized with the Sau3AI-XbaI fragment, coordinates 39819-40269
(Shehee et al., 1989) detecting the hypersensitive site at the promoter
of the mouse b -major gene, and then with the lacZ probe to detect
hypersensitive sites at the transgene.LacZ expression in transgenic embryos and fetuses
For the collection of mice at various developmental stage, transgenic
males from each line were kept with wild-type FVB female mice. The
day of the vaginal plug was taken as E0.5. The embryos were
dissected out of the decidua and fixed on ice in a solution containing
1% formaldehyde, 0.5% glutaraldehyde in PBS for 30 minutes. They
were then rinsed in embryo buffer (PBS, 0.02% NP40, 0.01% deoxy-
cholate, 2 mM MgCl2) and incubated in staining solution (1 mg/ml
5-bromo-4-chloro-3-indolyl-b -D-galacto-pyranoside (X-gal), 5 mM
K3Fe(CN)6, 5 mM K4Fe(CN)6 and 1 mM ethylene glycol-bis(b -
aminoethyl ether) N,N,N¢ ,N¢ -tetraacetic acid (EGTA) in embryo
buffer). After 3-4 hours at 37°C, or overnight at room temperature in
the dark, the staining reaction was stopped by removing this solution
and rinsing the embryos in PBS. The same procedure was followed
for E10.5 and E13.5 blood staining, except that the cells were fixed
for only 5 minutes.
In situ hybridization on erythroid cells
E10.5 embryonic blood from the heart or E13.5 liver cells from indi-
vidual fetuses were disrupted in 50 and 150 m l of PBS respectively.
20 m l of this cell suspension was fixed onto a poly(lysine)-coated slide
in 4% formaldehyde, 5% acetic acid for 20 minutes at room temper-
ature. The cells were then washed 3· for 10 minutes in PBS and stored
in 70% ethanol at - 20°C. The remains after collection of blood or
liver were stained for b -galactosidase to detect the transgenics.
Two probes were utilized for in situ hybridization. A nick-trans-
lated biotinylated lacZ probe for the detection of lacZ transcription,
and DIG-labelled mouse a intron-specific oligonucleotides to reveal
the erythroid cells. As a control, some of the slides were RNase-
treated and hybridized with these probes. Hybridizations were done
as described by Wijgerde et al. (1995) with a few modifications. The
lacZ hybridization mix contained 50% formamide and 10% dextran
sulphate. For antibody detection, the Tyramid amplification system
TSA of Dupont was used (Raap et al., 1995).
Tissue culture and cell transfection
Murine erythroleukemia cells (MEL, strain C88) were maintained in
DMEM plus 10% fetal calf serum. The construct m LCR-lacZ with
neomycin as selectable marker was linearized at the ScaI site and
transfected by electroporation as described (Antoniou et al., 1988;
Antoniou and Grosveld, 1990). Stably transfected MEL populations
were selected in G418 and induced to undergo erythroid differen-
tiation by the addition of DMSO to a final concentration of 2% (v/v)
for 2 days. The cells were collected and used for hypersensitive-site
mapping. The DNaseI-treated samples were cut with EcoRI and SacII.
The Southern blots were hybridized with the 1.9 kb fragment of 5¢ HS3
(Talbot et al., 1989) or the lacZ probe to detect the hypersensitive
sites.
RESULTS
Expression status of lacZ transgenes in mice as
analyzed by X-gal staining
In order to analyze the expression status of the LCR and its
individual hypersensitive sites (HS) with a ubiquitous
promoter, each of these sites (Talbot et al., 1989) was linked
to the minimal mouse Hsp68 promoter. This 80 bp promoter
contains a CCAAT box, an Sp1 binding site and a TATA box.
All these constructs used the bacterial b -galactosidase (lacZ)
gene as a reporter, to allow visualization of expression by X-
gal staining (Bonnerot and Nicolas, 1993). These constructs
were first tested in transgenic founder animals. Fetuses and
yolk sacs were collected at 13.5 days of development (hence-
forth referred to as E13.5) and analyzed by X-gal staining All
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Table 1. X-gal staining of transgenic founder fetuses at
E13.5
Number of X-gal staining in blood, Position 
Construct transgenic fetuses yolk sac and fetal liver effect
5¢ HS1-lacZ 5 2 3
5¢ HS2-lacZ 7 0 7
5¢ HS3-lacZ 6 5 1
5¢ HS4-lacZ 11 4 7
m LCR-lacZ 12 10 7
‘Position effect’ indicates ectopic expression, i.e. outside the erythroid
system.
genic fetuses from stable transgenic lines. (A) Control non-transgenic
2-lacZ; (D) 5¢ HS3-lacZ; (E) 5¢ HS4-lacZ; and (F) m LCR-lacZ. The fetal
n D and F. Ectopic expression, i.e. expression outside the erythroid
E. Original magnification, 8·.
Table 2. X-gal staining of transgenic lines
X-gal staining in 
embryonic erythroid Position 
Construct Lines cells E8.5-E10.5 effect
5¢ HS1-lacZ a No Yes
5¢ HS2-lacZ a No Yes
b No Yes
c No Yes
d No No
5¢ HS3-lacZ a Yes Yes
b Yes No
5¢ HS4-lacZ a No Yes
b No No
c No Yes
d No Yes
m LCR-lacZ a Yes Yes
b Yes No
‘Position effect’ indicates ectopic expression, i.e. outside the erythroid
system.
B C
E Ffetuses were typed for the transgene by Southern blot hybrid-
ization. The results are summarized in Table 1.
LacZ expression was observed in blood, yolk sac and fetal
liver of a few founder animals containing constructs with
5¢ HS1 or 5¢ HS4. However, no hematopoietic-specific staining
was observed in founder fetuses with 5¢ HS2. In most of the
5¢ HS1, 5¢ HS2 and 5 ¢ HS4 founders, X-gal staining was
observed in various other parts of the fetuses. This type of
staining corresponds to classical position effects, to which the
minimal Hsp68 promoter is
very sensitive (Kothary et al.,
1987, 1988, 1989). These
position effects show that the
transgenes are functional and
have not integrated in an inher-
ently closed chromatin domain
of the mouse genome. In sharp
contrast, X-gal staining could
be easily detected in the
erythroid cells of the yolk sac,
fetal liver and blood vessels in
the majority of founder fetuses
with either the m LCR or the
5¢ HS3 transgene. As expected,
ectopic expression was also
observed, since the LCR or
parts of it do not neutralize
position effects in non-erythroid
tissues (Grosveld et al., 1987). 
Previously, it has been shown
that each of the hypersensitive
sites of the LCR may have some
developmental specificity
(Fraser et al., 1993), and hence
it was possible that the absence
of erythroid staining in the
5¢ HS1, -2 and -4 founder fetuses
is due to the stage specificity of
these individual sites.
Therefore, we studied the
expression of the constructs in
stable transgenic lines at
different developmental stages.
The data for each of the estab-
lished stable transgenic lines are
summarized in Table 2. F1 or
F2 males from these lines were
mated with non-transgenic
Fig. 1. X-gal-stained E13.5 trans
fetus; (B) 5¢ HS1-lacZ; (C) 5¢ HS
liver is indicated with an arrow i
system, can be seen in B, C and 
A
Dfemales to collect embryos and fetuses at different develop-
mental time points.
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) X-gal staining pattern in the 5¢ HS3-lacZ line b. (A) Non-transgenic
bryo; the ring of blue cells at the base of the yolk sac is indicated by an
o. (D) Various stages observed in E8-8.5 transgenic embryos. (E) E9.5
e yolk sac. (F) E10.5 yolk sac staining. (G) E10.5 (left) and E11.5
eart is indicated by arrows, the dorsal aorta by arrowheads. Original
· (D,G); 50· (E). Data are shown for the 5¢ HS3-lacZ line b in Figs 2, 3
 identical results were obtained with the other 5¢ HS3-lacZ and both of
B C
E
GThese results revealed that, at E13.5, X-gal staining of the
erythroid cells could only be detected in the transgenic lines
containing the m LCR or 5 ¢ HS3 constructs (Fig. 1D,F). This
is in agreement with the data obtained from the founder
fetuses (Table 1). Staining of the erythroid system was not
seen for the other constructs (Fig. 1B,C,E). Again, expression
outside the erythroid system, due to position effects, was
observed in many of the lines with all of the constructs (Fig.
1 and Tables 1, 2).
The expression status of the transgenes at earlier stages in
mouse development was examined by X-gal staining of
embryos at various time points starting from the onset of
hematopoiesis at E7.5-8.
Embryos containing the
5 ¢ HS1, 5 ¢ HS2 and 5 ¢ HS4
transgenes showed no staining
in the yolk sac or blood cells
at any of the stages examined
(Table 2). However, the µLCR
and 5 ¢ HS3 lines showed 
the first erythroid-specific
staining at E8-8.5, with a ring
of blue cells observed at the
base of the yolk sac (Fig. 2B,
arrow). Later, X-gal staining
cells are found over the entire
yolk sac (Fig. 2C,D). In E9-
E10.5 embryos, the staining is
seen in the cells within the
blood capillaries (Fig. 2E-G),
the heart (Fig. 2G, arrows) and
the dorsal aorta (Fig. 2G,
arrowheads). In addition,
staining of the fetal liver is
observed in E13.5 fetuses
(Fig. 1D,F, arrows). Surpris-
ingly, very few blue cells are
found in adult blood from the
same transgenic lines (Fig.
3A). This prompted us to
study the blood from E10.5
and E13.5 transgenics in more
detail. While >98% of the
cells are lacZ-positive in
E10.5 blood (Fig. 3F), this
number decreases to around
50% in E13.5 blood (Fig. 3E).
Most of the cells staining at
the early stages are presum-
ably embryonic primitive
erythroid cells, since they are
large and nucleated (Fig.
3E,F). Strikingly, less than
10% lacZ-positive cells are
found in the fetal liver (Fig.
3C), the site of erythropoiesis
at E13.5 (see Fig. 1D,F,
arrows). These data therefore
suggest that the m LCR and
5 ¢ HS3 transgenes are active in
primitive cells of embryonic
Fig. 2. Developmental (E8-E11.5
E8 embryo. (B) E8 transgenic em
arrow. (C) E8.5 transgenic embry
transgenic embryo enclosed in th
(right) transgenic embryos; the h
magnification, 80· (A,B,C,F); 25
and 5, but it should be noted that
the µLCR-lacZ lines.
A
D
Forigin, but not in fetal- and adult-type definitive erythroid
cells. 
DNaseI hypersensitive site mapping in the fetal liver
of lacZ transgenic mice
The LCR is characterized by the presence of developmentally
stable, very strong, erythroid-specific DNaseI hypersensitive
sites (Grosveld et al., 1987; Jimenez et al., 1992b; Tuan et al.,
1985). To determine whether these hypersensitive sites are
correctly established in our transgenic mice, we examined the
chromatin structure in E13.5 liver of the lacZ transgenic lines
described above. Nuclei from the livers of E13.5 fetuses were
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Table 3. Percentage of cells actively transcribing the lacZ-
or the endogenous mouse a -globin genes as determined by
in situ hybridization
Percentage of 
Percentage of cells with 
Time cells with lacZ mouse a -globin 
points Cell type Line nuclear signal nuclear signals
E10.5 Blood 5 ¢ HS3-lacZ b 16 92
m LCR-lacZ b 15 97
E13.5 Fetal liver 5¢ HS3-lacZ b 0.5 97
m LCR-lacZ b 1.1 95
of blood and fetal liver cells from the 5¢ HS3-lacZ line b.
lood; (B) non-transgenic adult blood; (C) E13.5 transgenic liver cells;
nic liver cells; (E) E13.5 transgenic blood; and (F) E10.5 transgenic
fication, 400· .
B
D
Ftreated with DNaseI (Ellis et al., 1996), after which the purified
DNA was digested with EcoRI and Southern-blotted. As a
control, the Southern blots were first hybridized with a probe
detecting the hypersensitive site at the mouse b -major
promoter to assess DNaseI sensitivity. The blots were then
hybridized with a lacZ probe to detect hypersensitive sites at
the transgenes. As a reference, tail DNA from each transgenic
mouse line was cut with EcoRI and NcoI to show the position
of the Hsp68 promoter. To mark the positions of the core
elements of the LCR fragments, EcoRI-digested tail DNA was
recut with SpeI for 5¢ HS1, HindIII for 5¢ HS2, ApaI for 5¢ HS3
and SphI for 5¢ HS4 (Talbot et al., 1989).
The results obtained from this analysis on E13.5 liver show
that hypersensitive sites are not detectable at the correct
positions within any of the transgenes, while the hypersensi-
tive site at the mouse b -major promoter could be detected con-
sistently (Fig. 4). For example, the weak sensitivity seen in
DNA from the 5¢ HS2-lacZ line b (grey arrow in Fig. 4D) does
not map to the core fragment of 5¢ HS2, nor to the Hsp68
promoter and most likely reflects the
general, non-erythroid, DNaseI sensitiv-
ity associated with 5¢ HS2 (e.g. Ellis et
al., 1996). These results are not surpris-
ing for the lines with the 5¢ HS1, -2 and
-4 constructs, since we could not detect
erythroid-specific expression of the lacZ
gene in these mice. However, no DNaseI
hypersensitivity is observed in the DNA
from the lines with the m LCR and 5 ¢ HS3
constructs (Fig. 4B,E), even though lacZ
protein is easily detectable at this stage
(Fig. 1D,F; Fig. 3C). Since it is possible
that the lacZ gene was transcribed only
at earlier stages in fetal liver develop-
ment, we repeated the DNaseI fade-out
analysis on E12.5 livers of the m LCR and
5¢ HS3 lines. These results were also
negative (data not shown) and thus, we
conclude that the transgenes are in a
closed chromatin conformation in the
fetal liver. 
In situ hybridization to detect
active transcription of the
transgene
Since the numbers of erythroid cells that
can be obtained from E8.5-E10.5
embryos are too small for a DNaseI sen-
sitivity analysis (N. Gillemans, unpub-
lished results), we used in situ hybridiz-
ation as an alternative to monitor the
activity of the m LCR and 5¢ HS3 trans-
genes. To more closely examine when
and at what frequency the m LCR- and
5¢ HS3-lacZ transgenes are actively tran-
scribed, we analyzed specific transcrip-
tion of the lacZ gene at the single cell
level (Wijgerde et al., 1995). In situ
hybridization was performed on
erythroid cells from E10.5 blood and
E13.5 liver with a biotin-labelled lacZ
Fig. 3. X-gal staining 
(A) Transgenic adult b
(D) E13.5 non-transge
blood. Original magni
A
C
Eprobe to detect transcription of the transgenes. Oligonucleotide
mouse a -globin probes were used to establish the number of
erythroid cells in each preparation. The slides were analyzed
by confocal-or standard fluorescence microscopy.
When lacZ was used as probe, we observed a single nuclear
signal in a significant number (around 15%) of cells in E10.5
blood (Table 3; Fig. 5A, arrow). The much higher percentage
3996 R. Tewari and others
β-major
LacZ5'HS1
al Hsp68 promoter
EcoRI
SV40
polyA
µLCR-lacZ
[DNaseI]
N SpHS A
B
[DNaseI]
N Sp
5'HS2-lacZ
[DNaseI]
N H
β-major
D
[DNaseI]
5'HS4-lacZ
[DNaseI]
N N SA
β-major
F
sensitive site mapping. (A) Schematic drawing of the m LCR-lacZ
is indicated with a bar. (B-F) Hypersensitive site analysis in e13.5 liver
he DNA was digested with EcoRI (see Materials and Methods). For
ybridization detecting the hypersensitive site at the promoter of the
is shown below. The triangles indicate increasing amounts of DNaseI.
re indicated by arrows. (B) m LCR-lacZ line b; (C) 5¢ HS1-lacZ line a;
; (E) 5¢ HS3-lacZ line b; (F) 5¢ HS4-lacZ line a. Control lanes contain
coRI plus another enzyme to mark the position of the Hsp68 promoter
here hypersensitive sites should appear: N, NcoI (Hsp68 promoter),
HindIII (5¢ HS2), A, ApaI (5¢ HS3), S, SphI (5¢ HS4).of X-gal staining cells (Fig. 3F) suggests that the lacZ gene
may not be transcribed continuously, as has been observed in
transgenic mice carrying the human b -globin locus with small
deletions in the LCR (Milot et al., 1996). Hence, we conclude
that the hemizygous lacZ gene is actively transcribed at this
stage. Contrasting observations were made with E13.5 liver
cells where only a few cells (0.5-1%) had a nuclear signal
(Table 3 and Fig. 5B). The control hybridization for expression
of the homozygous mouse a -globin genes detected two nuclear
signals in >90% of the cells (Table 3; Fig. 5C, arrowheads),
confirming that these cells are of the erythroid lineage. No
nuclear signal was detected in RNase-treated or lacZ- negative
cells at either stage when hybridized with the lacZ probe (Fig.
5D and data not shown). Thus, we conclude that at E10.5,
many of the erythroid cells from the m LCR and 5¢ HS3 lines
are actively transcribing the lacZ gene. As development
advances, the percentage of actively transcribing cells becomes
considerably lower. This is in agreement
with our DNaseI fade-out analysis, in
which <1% of cells with an active gene
in E13.5 liver would be too low to detect
hypersensitive sites at the transgene. 
DNaseI hypersensitive site
mapping in MEL cell populations
with m LCR-lacZ
The absence of hypersensitive sites in
the m LCR-lacZ and 5 ¢ HS3-lacZ trans-
genes raised the question whether these
constructs are intrinsically inactive in
the adult erythroid environment. To
investigate this, we transfected the
m LCR-lacZ construct into murine ery-
throleukemia (MEL) cells. These cells
represent the pro-erythroblast stage of
adult cell differentiation. Stable clones
were obtained by selection with G418,
thus assuring integration into an active
area of the chromatin. The cell popula-
tions were expanded and induced with
DMSO to undergo erythroid differen-
tiation for 2 days. These cells were then
analyzed for DNaseI sensitivity, as
described earlier (Philipsen et al., 1990).
The blots were hybridized with a 5 ¢ HS3
probe, because the lacZ probe
hybridizes to vector sequences preclud-
ing a straightforward interpretation of
the results (not shown). Interestingly,
we find that all four DNaseI hypersensi-
tive sites are strongly represented, as
shown in Fig. 6. The sub-band corre-
sponding to the hypersensitive site at
5 ¢ HS4 runs just below the parent restric-
tion band and is not well resolved.
However, the hypersensitive sites at
5 ¢ HS1 and the promoter (which
comigrate), 5 ¢ HS2 and 5 ¢ HS3 are found.
Thus, we conclude that the m LCR-lacZ
construct is not intrinsically inactive in
the adult erythroid environment.
5'HS25'HS35'HS4
minim
A
5'HS1-lacZ
β-major
C
5'HS3-lacZ
β-major
E
Fig. 4. DNaseI hyper
construct. The probe 
of transgenic lines. T
each line, a control h
mouse b -major gene 
Hypersensitive sites a
(D) 5 ¢ HS2-lacZ line b
DNA digested with E
or the LCR regions w
Sp, SpeI (5¢ HS1), H, DISCUSSION
Activation of lacZ transgenes by the b -globin LCR
Previous studies involving the human b -globin LCR and its
individual hypersensitive sites 5¢ HS1-4 have shown that these
regulatory elements confer position-independent, copy-
number dependent expression to the b -globin gene in trans-
genic mice (Caterina et al., 1991, 1994; Ellis et al., 1993;
Fraser et al., 1990; Philipsen et al., 1990, 1993; Pruzina et al.,
1991, 1994; Ryan et al., 1989; Talbot et al., 1990). It has not
been established whether the LCR can direct erythroid-specific
expression in the absence of any globin gene sequences. We
linked the m LCR or individual HS elements to a simple 80 bp
promoter derived from the mouse Hsp68 gene that does not
have any developmental or tissue specificity (Kothary et al.,
1987, 1988, 1989).
We analyzed the ability of the m LCR and 5¢ HS1, 5 ¢ HS2,
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Fig. 5. In situ hybridization to detect active transcription of the lacZ
transgene in the 5¢ HS3-lacZ line b. (A) E10.5 embryonic blood
hybridized with the lacZ probe. A single nuclear signal
corresponding to active transcription of the hemizygous lacZ gene is
indicated by an arrow. (B) E13.5 fetal liver cells hybridized with the
lacZ probe; there are virtually no cells with nuclear signal (Table 3).
(C) Control hybridization with oligonucleotide probes detecting
transcription of the homozygous mouse a -globin gene; two
transcription foci per nucleus are indicated by arrowheads. (D) E10.5
blood from a control non-transgenic mouse hybridized with the lacZ
probe. Original magnification, 630·.
Fig. 6. Hypersensitive
site mapping of the
m LCR-lacZ construct
in MEL cells. MEL
cells were stably
transfected with the
m LCR-lacZ construct,
and hypersensitive site
analysis was performed
as described (Philipsen
et al., 1990). The DNA
was digested with
EcoRI and SacII,
Southern blotted and
hybridized with the 1.9 kb 5¢ HS3 fragment [see Fig. 4A; Talbot et al.
(1989)]. Other details are as in Fig. 4.
[DNaseI]
µLCR-lacZ
P/5'HS1
5'HS2
5'HS3
(5'HS4)
A B
C D5¢ HS3 and 5¢ HS4 to activate this reporter construct in the
erythroid cells of transgenic mice. The results show that only
the complete m LCR and 5¢ HS3 can direct expression of the
lacZ reporter in the erythroid system of the developing mouse.
While erythroid-specific staining was observed in some of the
E13.5 founder fetuses analyzed for 5¢ HS1 and 5¢ HS4, none of
the established transgenic lines with these constructs showed
such a staining at any stage of development. This indicates that
5¢ HS1 and 5 ¢ HS4 need other elements to activate erythroid-
specific transcription. 
5 ¢ HS2 is believed to be a crucial component of the LCR.This part of the LCR shows the highest degree of evolution-
ary conservation (Hardison et al., 1993; Jimenez et al., 1992a).
Its function has been studied in great detail in transfection
(Hardison et al., 1993; Moon and Ley, 1991; Tuan et al.,
1989), transgenic (Caterina et al., 1991, 1994; Ellis et al.,
1993, 1996; Ryan et al., 1989; Talbot et al., 1990) and knock-
out experiments (Fiering et al., 1995). To our surprise, we
could not detect any erythroid-specific expression with the
construct containing 5 ¢ HS2, neither in E13.5 day founders, nor
at any stage of development in four established lines. Thus we
conclude that 5 ¢ HS2 is also unable to activate the non-
erythroid Hsp68 promoter in the erythroid lineage. The fre-
quently observed ectopic expression (i.e. expression outside
the erythroid cells) in 5 ¢ HS2 transgenics shows that this
construct is not intrinsically inactive. Rather, these results
suggest that 5 ¢ HS2 is dependent on local elements provided
by the b -globin gene for erythroid-specific activation. Prelim-
inary data show that these elements might reside within the
first 800 bp of the b -globin promoter, since we have one E13.5
founder with 5 ¢ HS2 and the 5 ¢ -800 b -globin promoter driving
the lacZ gene that shows extensive staining of the erythroid
system (not shown).
It should be noted that all the transgenes were present as
multi-copy concatamers. Previous studies from our laboratory
have shown that only 5¢ HS3 of the LCR is capable of activat-
ing the b -globin gene in single-copy transgenic mice. 5¢ HS2
was only active when present in a multi-copy configuration
(Ellis et al., 1996). In contrast, it appears from the present study
that 5¢ HS2 is not able to activate the minimal Hsp68 promoter,
even in multi-copy transgenics. Our data corroborate those of
Ellis et al. (1996) that 5¢ HS3 is the most important hypersen-
sitive site of the b -globin LCR.
Developmental expression pattern of the lacZ
transgenes
In the lines with the m LCR or 5¢ HS3, expression of the lacZ
transgene could first be detected at E8-8.5 as a ring of cells
around the base of the yolk sac. This is the first site of ery-
thropoiesis in the developing mammalian embryo (Russell and
Bernstein, 1966). Later, as vascularization occurs, lacZ-positive
cells are found in the developing circulatory system of the
embryo. In E10.5-11 blood, the vast majority of the circulating
primitive erythrocytes are lacZ-positive. A paradox occurs in
E13.5 liver. Although the erythroid fetal liver can be easily
stained for the presence of the lacZ protein, large numbers of
erythrocytes begin to appear in the circulation that do not stain
with X-gal. We believe that these data can be explained by the
model for the development of the hematopoietic system
proposed by Dzierzak and Medvinsky (1995). According to this
model, the fetal liver is first colonized by a wave of primitive
hematopoietic precursor cells derived from the yolk sac. A
second wave of colonization occurs when definitive stem cells
originating from the AGM (Aorta, Gonads, Mesonephros)
region migrate to the fetal liver. In our transgenic mice, the
lacZ-positive cells in the fetal liver would be derived from the
yolk sac precursor cells. These cells actively expressed the
transgene at the embryonic stages of development. Although
they have switched off the lacZ gene in the E13.5 fetal liver, as
we have shown by in situ hybridization, they still contain lacZ
protein and mRNA. Hence, these cells may stain lacZ-positive
even after a number of cell divisions. The lacZ-negative cells
3998 R. Tewari and othersin the circulation would be derived from fetal liver cells origi-
nating from the AGM region, which have never expressed the
lacZ gene at detectable levels. This model implies that the lacZ
gene has a repressive effect on the LCR in definitive but not in
primitive erythropoiesis. Recent observations of Guy et al.
(1996) and Robertson et al. (1995) are consistent with this
hypothesis, and preclude the simple explanation that our obser-
vations are an artefact of the particular transgene construct that
we have used. These authors found that the presence of the lacZ
gene, even in the presence of a complete b -globin gene (Guy et
al., 1996), interferes with LCR function (Robertson et al.,
1995). Unfortunately, these groups did not present data on early
embryonic time points. The absence of DNaseI hypersensitive
sites in E13.5 fetal liver suggests that the repression is due to
heterochromatization of the transgenes (Adams and Workman,
1993; Elgin, 1990; Hebbes et al., 1992; Patterton and Wolffe,
1996), and not caused by the inability of the LCR to interact
with the model promoter we employed. Recent data of knock-
out experiments in the mouse b -globin locus show that non-
erythroid promoters can be activated very efficiently by the
LCR (Fiering et al., 1995; Hug et al., 1996; Kim et al., 1992;
Nandi et al., 1988; Shehee et al., 1993). Consistent with these
observations, we can detect hypersensitive sites at the transgene
when transfected into MEL cells. Mechanistically, the lacZ
gene could serve as a nucleation point for heterochromatization
in definitive erythroid cells, resulting in repression of the trans-
genes in mice. In tissue culture, these events are eliminated
because the selection procedure only leaves cells in which inte-
gration has occurred in open areas of chromatin, to allow
expression of the resistance marker. The results suggest that the
m LCR-lacZ construct is active when integrated in such
chromatin in adult erythroid cells, but that it is suppressed when
it integrates in closed chromatin domains, as is probably the
case in transgenic mice. The reason for the inactivation in mice
is presently unknown, but we have ruled out the possibility that
it is caused by progressive methylation of the transgenes (results
not shown).
Previous studies have shown that the µLCR and 5¢ HS3 direct
high level expression of the b -globin gene in transgenic mice
(Ellis et al., 1996; Philipsen et al., 1990, 1993; Talbot et al.,
1989); the data in this paper indicate that the presence of this
gene is a requirement for the activity of the m LCR and 5¢ HS3
in fetal and adult erythroid cells.
Hypersensitive site formation in the LCR
Our data are in apparent contradiction with a number of
published observations regarding hypersensitive site formation
in the LCR. Two independent laboratories have studied this for
5¢ HS2 and 5¢ HS4. In the case of 5 ¢ HS2, Pawlik et al. (1995)
have shown that 5¢ HS2, in the absence of a gene, has a DNaseI-
hypersensitive site in transgenic mice. We also observe weak
hypersensitivity at 5¢ HS2 in our transgenic lines, and suggest
that this corresponds to the ubiquitous hypersensitive site asso-
ciated with the human 5¢ HS2 (Ellis et al., 1996). This hyper-
sensitive site is located outside the core fragment of 5¢ HS2,
where the erythroid-specific activity resides.
Transgenic mice experiments also suggest that 5¢ HS4 can
autonomously form a hypersensitive site (Lowrey et al., 1992).
However, since only one transgenic line was analyzed in this
study, the transgene may have integrated in an area of open
chromatin. Stamatoyannopoulos et al. (1995) have reported onthe formation of 5¢ HS4 in the presence of 5¢ HS3 in transfec-
tion experiments in MEL cells. As we show here, we can detect
hypersensitive sites when we transfect the µLCR-lacZ
construct into MEL cells, but not in the transgenic lines. 
Our data are compatible with those obtained for the chicken
b -globin locus in transgenic mice. These data suggest that
hypersensitive site formation in the chicken 3¢ enhancer is
dependent on the presence of an active promoter (Reitman et
al., 1993). We have shown that in E13.5 fetal liver the m LCR
and 5¢ HS3 transgenes are in a closed chromatin conformation,
and that transcription of the lacZ gene is not detectable in these
cells. Hence, as in the chicken case (Reitman et al., 1993), a
closed promoter correlates with the absence of hypersensitive
sites in the LCR.
Perspective
The data in this paper show that the m LCR and 5¢ HS3 can
activate the minimal Hsp68 promoter in transgenic mice. The
other HS elements of the LCR are inactive and therefore
require additional elements of the b -globin locus for their
activity. The expression of the m LCR and 5¢ HS3 transgenes is
specific for embryonic, primitive erythropoiesis. Hence, these
mice are useful tools for the study of these first erythroid cells.
Recently, gene-targeting experiments have implicated a
number of transcription factors in the development of the
erythroid cell (reviewed in Shivdasani and Orkin, 1996). The
role of these transcription factors in the activating function of
the m LCR and 5¢ HS3 in primitive erythropoiesis can now be
addressed directly by breeding our transgenes into these knock-
out backgrounds.
We would like to thank Drs Elaine Dzierzak and Dies Meijer for
their thoughtful comments on the manuscript, Ms An Langeveld for
help with the in situ hybridizations, Mirko Kuit for his expert help
with photography, and Adriaan Houtsmuller for confocal microscopy.
This work was supported by an NWO grant to F.G.
REFERENCES
Adams, C. C. and Workman, J. L. (1993). Nucleosome displacement in
transcription. Cell 72, 305-8.
Antoniou, M., deBoer, E., Habets, G. and Grosveld, F. (1988). The human
beta-globin gene contains multiple regulatory regions: identification of one
promoter and two downstream enhancers. EMBO J. 7, 377-84.
Antoniou, M. and Grosveld, F. (1990). beta-globin dominant control region
interacts differently with distal and proximal promoter elements. Genes Dev.
4, 1007-13.
Bonnerot, C. and Nicolas, J.-F. (1993). Application of lacZ gene fusions to
postimplantation development. Meth. Enzymol. 225, 451-469.
Caterina, J. J., Ciavatta, D. J., Donze, D., Behringer, R. R. and Townes, T.
M. (1994). Multiple elements in human beta-globin locus control region 5¢
HS 2 are involved in enhancer activity and position-independent, transgene
expression. Nucleic Acids Res. 22, 1006-11.
Caterina, J. J., Ryan, T. M., Pawlik, K. M., Palmiter, R. D., Brinster, R. L.,
Behringer, R. R. and Townes, T. M. (1991). Human beta-globin locus
control region: analysis of the 5¢ DNase I hypersensitive site HS 2 in
transgenic mice. Proc. Natl Acad. Sci. USA 88, 1626-30.
Driscoll, M. C., Dobkin, C. S. and Alter, B. P. (1989). Gamma delta beta-
thalassemia due to a de novo mutation deleting the 5¢ beta-globin gene
activation-region hypersensitive sites. Proc. Natl Acad. Sci. USA 86, 7470-4.
Dzierzak, E. and Medvinsky, A. (1995). Mouse embryonic hematopoiesis.
Trends Genet. 11, 359-66.
Elgin, S. C. (1990). Chromatin structure and gene activity. Curr. Opin. Cell
Biol. 2, 437-45.
Ellis, J., Talbot, D., Dillon, N. and Grosveld, F. (1993). Synthetic human
3999b -globin LCR confers embryonic lacZ gene expressionbeta-globin 5¢ HS2 constructs function as locus control regions only in
multicopy transgene concatamers. EMBO J. 12, 127-34.
Ellis, J., Tan-Un, K. C., Harper, A., Michalovich, D., Yannoutsos, N.,
Philipsen, S. and Grosveld, F. (1996). A dominant chromatin-opening
activity in 5¢ hypersensitive site 3 of the human beta-globin locus control
region. EMBO J. 15, 562-568.
Fiering, S., Epner, E., Robinson, K., Zhuang, Y., Telling, A., Hu, M.,
Martin, D. I., Enver, T., Ley, T. J. and Groudine, M. (1995). Targeted
deletion of 5¢ HS2 of the murine beta-globin LCR reveals that it is not
essential for proper regulation of the beta-globin locus. Genes Dev. 9, 2203-
13.
Forrester, W. C., Epner, E., Driscoll, M. C., Enver, T., Brice, M.,
Papayannopoulou, T. and Groudine, M. (1990). A deletion of the human
beta-globin locus activation region causes a major alteration in chromatin
structure and replication across the entire beta-globin locus. Genes Dev. 4,
1637-49.
Fraser, P., Hurst, J., Collis, P. and Grosveld, F. (1990). DNaseI
hypersensitive sites 1, 2 and 3 of the human beta-globin dominant control
region direct position-independent expression. Nucleic Acids Res. 18, 3503-
8.
Fraser, P., Pruzina, S., Antoniou, M. and Grosveld, F. (1993). Each
hypersensitive site of the human beta-globin locus control region confers a
different developmental pattern of expression on the globin genes. Genes
Dev. 7, 106-13.
Grosveld, F., van Assendelft, G. B., Greaves, D. R. and Kollias, G. (1987).
Position-independent, high-level expression of the human beta-globin gene
in transgenic mice. Cell 51, 975-85.
Guy, L.-G., Kothary, R., DeRepentigny, Y., Delvoye, N., Ellis, J. and Wall,
L. (1996). The beta-globin locus control region enhances transcription but
does not confer position-independent expression onto the lacZ gene in
transgenic mice. EMBO J. 15, 3713-3721.
Hardison, R., Xu, J., Jackson, J., Mansberger, J., Selifonova, O., Grotch,
B., Biesecker, J., Petrykowska, H. and Miller, W. (1993). Comparative
analysis of the locus control region of the rabbit beta-like gene cluster: HS3
increases transient expression of an embryonic epsilon-globin gene. Nucleic
Acids Res. 21, 1265-72.
Hebbes, T. R., Thorne, A. W., Clayton, A. L. and Crane-Robinson, C.
(1992). Histone acetylation and globin gene switching. Nucleic Acids Res.
20, 1017-22.
Hug, B. A., Wesselschmidt, R. L., Fiering, S., Bender, M. A., Epner, E.,
Groudine, M. and Ley, T. J. (1996). Analysis of mice containing a targeted
deletion of beta- globin locus control region 5¢ hypersensitive site 3. Mol.
Cell. Biol. 16, 2906-2912.
Jimenez, G., Gale, K. B. and Enver, T. (1992a). The mouse beta-globin locus
control region: hypersensitive sites 3 and 4. Nucleic Acids Res. 20, 5797-803.
Jimenez, G., Griffiths, S. D., Ford, A. M., Greaves, M. F. and Enver, T.
(1992b). Activation of the beta-globin locus control region precedes
commitment to the erythroid lineage. Proc. Natl Acad. Sci. USA 89, 10618-22.
Kim, C. G., Epner, E. M., Forrester, W. C. and Groudine, M. (1992).
Inactivation of the human beta-globin gene by targeted insertion into the
beta-globin locus control region. Genes Dev. 6, 928-38.
Kioussis, D., Vanin, E., deLange, T., Flavell, R. A. and Grosveld, F. G.
(1983). Beta-globin gene inactivation by DNA translocation in gamma beta-
thalassaemia. Nature 306, 662-6.
Kollias, G., Wrighton, N., Hurst, J. and Grosveld, F. (1986). Regulated
expression of human A gamma-, beta- and hybrid gamma beta-globin genes
in transgenic mice: manipulation of the developmental expression patterns.
Cell 46, 89-94.
Kothary, R., Clapoff, S., Brown, A., Campbell, R., Peterson, A. and
Rossant, J. (1988). A transgene containing lacZ inserted into the dystonia
locus is expressed in neural tube. Nature 335, 435-7.
Kothary, R., Clapoff, S., Darling, S., Perry, M. D., Moran, L. A. and
Rossant, J. (1989). Inducible expression of an hsp68-lacZ hybrid gene in
transgenic mice. Development 105, 707-14.
Kothary, R., Perry, M. D., Moran, L. A. and Rossant, J. (1987). Cell-
lineage-specific expression of the mouse hsp68 gene during embryogenesis.
Dev. Biol. 121, 342-8.
Lowrey, C. H., Bodine, D. M. and Nienhuis, A. W. (1992). Mechanism of
DNase I hypersensitive site formation within the human globin locus control
region. Proc. Natl Acad. Sci. USA 89, 1143-7.
Milot, E., Strouboulis, J., Trimborn, T., Wijgerde, M., De Boer, E.,
Langeveld, A., Tan-Un, K., Vergeer, W., Yannoutsos, N., Grosveld, F.
and Fraser, P. (1996). Heterochromatin effect on the frequency and duration
of LCR mediated gene transcription. Cell, in press.Moon, A. M. and Ley, T. J. (1991). Functional properties of the beta-globin
locus control region in K562 erythroleukemia cells. Blood 77, 2272-84.
Nandi, A. K., Roginski, R. S., Gregg, R. G., Smithies, O. and Skoultchi, A.
I. (1988). Regulated expression of genes inserted at the human chromosomal
beta-globin locus by homologous recombination. Proc. Natl Acad. Sci. USA
85, 3845-9.
Patterton, D. and Wolffe, A. P. (1996). Developmental roles for chromatin
and chromosomal structure. Dev. Biol. 173, 2-13.
Pawlik, K. M. and Townes, T. M. (1995). Autonomous, erythroid-specific
DNase I hypersensitive site formed by human beta-globin locus control
region (LCR) 5¢ HS 2 in transgenic mice. Dev. Biol. 169, 728-32.
Philipsen, S., Pruzina, S. and Grosveld, F. (1993). The minimal requirements
for activity in transgenic mice of hypersensitive site 3 of the beta globin locus
control region. EMBO J. 12, 1077-85.
Philipsen, S., Talbot, D., Fraser, P. and Grosveld, F. (1990). The beta-globin
dominant control region: hypersensitive site 2. EMBO J. 9, 2159-67.
Pruzina, S., Antoniou, M., Hurst, J., Grosveld, F. and Philipsen, S. (1994).
Transcriptional activation by hypersensitive site three of the human beta-
globin locus control region in murine erythroleukemia cells. Biochim.
Biophys. Acta 9, 351-60.
Pruzina, S., Hanscombe, O., Whyatt, D., Grosveld, F. and Philipsen, S.
(1991). Hypersensitive site 4 of the human beta globin locus control region.
Nucleic Acids Res. 19, 1413-9.
Raap, A. K., van de Corput, M. P., Vervenne, R. A., van Gijlswijk, R. P.,
Tanke, H. J. and Wiegant, J. (1995). Ultra-sensitive FISH using
peroxidase-mediated deposition of biotin- or fluorochrome tyramides. Hum.
Mol. Genet. 4, 529-34.
Reitman, M., Lee, E., Westphal, H. and Felsenfeld, G. (1993). An
enhancer/locus control region is not sufficient to open chromatin. Mol. Cell
Biol. 13, 3990-8.
Robertson, G., Garrick, D., Wu, W., Kearns, M., Martin, D. and Whitelaw,
E. (1995). Position-dependent variegation of globin transgene expression in
mice. Proc. Natl Acad. Sci. USA 92, 5371-5.
Russell, E. S. and Bernstein, S. E. (1966). Blood and blood formation. In
Biology of the Laboratory Mouse, Second Edition (ed. E.L. Green), pp. 351-
372. New York, McGraw-Hill.
Ryan, T. M., Behringer, R. R., Martin, N. C., Townes, T. M., Palmiter, R.
D. and Brinster, R. L. (1989). A single erythroid-specific DNase I super-
hypersensitive site activates high levels of human beta-globin gene
expression in transgenic mice. Genes Dev. 3, 314-23.
Shehee, W. R., Loeb, D. D., Adey, N. B., Burton, F. H., Casavant, N. C.,
Cole, P., Davies, C. J., McGraw, R. A., Schichman, S. A., Severynse, D.
M., Voliva, C. F., Weyter, F. W., Wisely, G. B., Edgell, M. H. and
Hutchison, C. A. III (1989). Nucleotide sequence of the BALB/c mouse
beta-globin complex. J. Mol. Biol. 205, 41-62.
Shehee, W. R., Oliver, P. and Smithies, O. (1993). Lethal thalassemia after
insertional disruption of the mouse major adult beta-globin gene. Proc. Natl
Acad. Sci. USA 90, 3177-81.
Shivdasani, R. A. and Orkin, S. H. (1996). The transcriptional control of
hematopoiesis. Blood 87, 4025-4039.
Stamatoyannopoulos, J. A., Goodwin, A., Joyce, T. and Lowrey, C. H.
(1995). NF-E2 and GATA binding motifs are required for the formation of
DNase I hypersensitive site 4 of the human beta-globin locus control region.
EMBO J. 14, 106-16.
Talbot, D., Collis, P., Antoniou, M., Vidal, M., Grosveld, F. and Greaves, D.
R. (1989). A dominant control region from the human beta-globin locus
conferring integration site-independent gene expression. Nature 338, 352-5.
Talbot, D., Philipsen, S., Fraser, P. and Grosveld, F. (1990). Detailed
analysis of the site 3 region of the human beta-globin dominant control
region. EMBO J. 9, 2169-77.
Taramelli, R., Kioussis, D., Vanin, E., Bartram, K., Groffen, J., Hurst, J.
and Grosveld, F. G. (1986). Gamma delta beta-thalassaemias 1 and 2 are the
result of a 100 kbp deletion in the human beta-globin cluster. Nucleic Acids
Res. 14, 7017-29.
Tuan, D., Solomon, W., Li, Q. and London, I. M. (1985). The ‘beta-like-
globin’ gene domain in human erythroid cells. Proc. Natl Acad. Sci. USA 82,
6384-8.
Tuan, D. Y., Solomon, W. B., London, I. M. and Lee, D. P. (1989). An
erythroid-specific, developmental-stage-independent enhancer far upstream
of the human ‘beta-like globin’ genes. Proc. Natl Acad. Sci. USA 86, 2554-8.
Wijgerde, M., Grosveld, F. and Fraser, P. (1995). Transcription complex
stability and chromatin dynamics in vivo. Nature 377, 209-13.
(Accepted 10 September 1996)
